首页> 美国卫生研究院文献>Cancers >Combined Systemic and Hepatic Artery Infusion Pump Chemo-Therapy as a Liver-Directed Therapy for Colorectal Liver Metastasis-Review of Literature and Case Discussion
【2h】

Combined Systemic and Hepatic Artery Infusion Pump Chemo-Therapy as a Liver-Directed Therapy for Colorectal Liver Metastasis-Review of Literature and Case Discussion

机译:组合全身和肝动脉输注泵化疗治疗作为肝脏定向治疗的结肠直肠肝转移 - 审查文学和案例讨论

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Liver metastasis is a major therapeutic challenge and common cause of death for patients with colorectal cancer. While systemic treatment especially chemotherapy remains the mainstay of treatment, selected patients with liver-only metastasis may further benefit from liver-directed therapies. Direct infusion of chemotherapy into the liver metastases via an implantable hepatic arterial infusion pump (HAIP) is potentially an effective way to improve treatment response and survival in selected patients. Here, we reviewed the literature utilizing HAIP as a liver-directed modality alone and in combination with systemic chemotherapy. We discussed two cases who were successfully treated with this combinatorial approach and achieved remission or prolongation of disease control. We discussed the limitations, toxicities of combined systemic and HAIP modalities. Lastly, we provided insights on the use of HAIP in the modern era of systemic treatment for colorectal cancer patients with liver metastasis.
机译:肝转移是结直肠癌患者的主要治疗挑战和常见的死因。虽然系统性治疗尤其是化疗仍然是治疗的主干,但肝脏转移的选定患者可能从肝导向的疗法中进一步受益。通过可植入的肝动脉输注泵(HAIP)将化疗直接注入肝脏转移中,可能是改善选定患者的治疗响应和存活的有效途径。在这里,我们通过单独使用HAIP作为肝脏定向的模态并与全身化疗组合进行了审查的文献。我们讨论了两种案例,以这种组合方法成功治疗并实现了疾病控制的缓解或延长。我们讨论了局限性,组合系统性和Haip模式的局限性,毒性。最后,我们为肝脏转移的结肠直肠癌患者的现代化时代使用了对HAIP的使用见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号